Cargando…

A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales

BACKGROUND: Postnatal and antenatal anti-D prophylaxis have dramatically reduced maternal sensitisations and cases of rhesus disease in babies born to women with RhD negative blood group. Recent scientific advances mean that non-invasive prenatal diagnosis (NIPD), based on the presence of cell-free...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczepura, Ala, Osipenko, Leeza, Freeman, Karoline
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034710/ https://www.ncbi.nlm.nih.gov/pubmed/21244652 http://dx.doi.org/10.1186/1471-2393-11-5

Ejemplares similares

Young people’s preferences for the use of emerging technologies for asymptomatic regular chlamydia testing and management: a discrete choice experiment in England
por: Eaton, Sue, et al.
Publicado: (2019)

Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping
por: Stensrud, Monica, et al.
Publicado: (2023)

Implementation of high‐throughput non‐invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross‐sectional survey of maternity units and expert interviews
por: Ryczek, Edyta, et al.
Publicado: (2020)

Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis
por: Koelewijn, JM, et al.
Publicado: (2009)

Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review
por: Runkel, Britta, et al.
Publicado: (2020)

RHD genotyping to resolve weak and discrepant RhD patient phenotypes
por: Barriteau, Christina M., et al.
Publicado: (2022)

Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD
por: Clausen, Frederik Banch, et al.
Publicado: (2013)

Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention Program
por: Tiblad, Eleonor, et al.
Publicado: (2013)

Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran
por: Moezzi, Leili, et al.
Publicado: (2016)

The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals
por: Ying, Yanling, et al.
Publicado: (2021)

Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study
por: Chitty, Lyn S, et al.
Publicado: (2014)

Audit of data redaction practices in NICE technology appraisals from 1999 to 2019
por: Osipenko, Leeza
Publicado: (2021)

A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women
por: Dündar Yenilmez, Ebru, et al.
Publicado: (2018)

RHD Genotyping by Molecular Analysis of Hybrid Rhesus box in RhD-Negative Blood Donors from Iran
por: Khosroshahi, Behzad Nazel, et al.
Publicado: (2018)

RHD exon 5, 7 and 10 targeted non-invasive prenatal screening of fetal Rhesus-D (RhD) in selected RhD negative pregnant women in Ethiopia
por: Niguse, Birhanu, et al.
Publicado: (2022)

RHD Genotypes in a Chinese Cohort of Pregnant Women
por: Zhang, Jianjun, et al.
Publicado: (2021)

Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status
por: Legler, Tobias J., et al.
Publicado: (2021)

Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fy(a) antigens
por: Alford, Brian, et al.
Publicado: (2023)

Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018
por: Osipenko, Leeza, et al.
Publicado: (2023)

Oral Fluid Testing during 10 Years of Rubella Elimination, England and Wales
por: Manikkavasagan, Gayatri, et al.
Publicado: (2010)

Oral Fluid Testing for Pertussis, England and Wales, June 2007–August 2009
por: Campbell, Helen, et al.
Publicado: (2014)

Human T-lymphotropic viruses (HTLV) in England and Wales, 2004 to 2013: testing and diagnoses
por: Ireland, Georgina, et al.
Publicado: (2017)

Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands
por: de Haas, Masja, et al.
Publicado: (2016)

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice
por: Kent, Julie, et al.
Publicado: (2014)

Improved library preparation protocols for amplicon sequencing-based noninvasive fetal genotyping for RHD-positive D antigen-negative alleles
por: Hori, Asuka, et al.
Publicado: (2021)

Lunacy in England and Wales
Publicado: (1882)

Smallpox in England and Wales
Publicado: (1924)

Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus
por: Papasavva, Thessalia, et al.
Publicado: (2016)

Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland
por: Schimanski, Bernd, et al.
Publicado: (2023)

Outcomes and costs of blunt trauma in England and Wales
por: Christensen, Michael C, et al.
Publicado: (2008)

The Cost of the National Health Service in England and Wales
por: Tredgold, R. F.
Publicado: (1956)

The Cost of Cardiac Rehabilitation Services in England and Wales
por: Gray, Alastair M, et al.
Publicado: (1997)

Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma
por: Ahmadi, Mohammad Hossein, et al.
Publicado: (2022)

Performance of Droplet Digital PCR in Non-Invasive Fetal RHD Genotyping - Comparison with a Routine Real-Time PCR Based Approach
por: Svobodová, Iveta, et al.
Publicado: (2015)

The (mis)use of fetal viability as the determinant of non-criminal abortion in the Netherlands and England and Wales
por: Halliday, Samantha, et al.
Publicado: (2023)

Impact of a confirmatory RhD test on the correct serologic typing of blood donors
por: Schmidt, Luciana Cayres, et al.
Publicado: (2015)

Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors
por: Jentzsch, Valerie, et al.
Publicado: (2023)

High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis
por: Yang, Huiqin, et al.
Publicado: (2019)

Exploring the Risk Posed by Animals with an Inconclusive Reaction to the Bovine Tuberculosis Skin Test in England and Wales
por: May, Elizabeth, et al.
Publicado: (2019)

Coroners' records in England and Wales
por: Bowman, Marion
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_84btn27f1sn27tliki39oghi3p